. 2024 Oct 21;14(45):32978–32991. doi: 10.1039/d4ra06394e
This journal is © The Royal Society of Chemistry
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.
Fig. 2. Structures of dual EGFR/HER2 inhibitors V and VI.
